Health
CVS Eyes Up to $2.5 Billion Bond Sale as It Buys Back Debt
- CVS holding fixed income investor calls for junior notes
- Company buying back up to $2 billion of Aetna, CVS notes
People walk into a CVS Health Corp. store in Washington, DC.
Photographer: Zach Gibson/BloombergThis article is for subscribers only.
CVS Health Corp. is talking to investors about possibly selling as much as $2.5 billion of bonds, according to people with knowledge of the matter.
The health care company asked Barclays Plc, Citigroup Inc., and Goldman Sachs Group Inc. to arrange investor calls on Monday, according to a person with knowledge of the matter.